IGC Pharma Inc (AMEX: IGC) has experienced a decline in its stock price by -4.67 compared to its previous closing price of 0.35. However, the company has seen a fall of -10.55% in its stock price over the last five trading days. businesswire.com reported 2024-09-18 that POTOMAC, Md.–(BUSINESS WIRE)– #AD–IGC Pharma Announces Additional Data Supporting IGC-AD1 as an Alzheimer’s Treatment.
Is It Worth Investing in IGC Pharma Inc (AMEX: IGC) Right Now?
Company’s 36-month beta value is 1.27.Analysts have differing opinions on the stock, with 2 analysts rating it as a “buy,” 0 as “overweight,” 0 as “hold,” and 0 as “sell.”
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
The public float for IGC is 52.02M, and currently, short sellers hold a 2.53% ratio of that floaft. The average trading volume of IGC on September 18, 2024 was 253.07K shares.
IGC’s Market Performance
IGC’s stock has seen a -10.55% decrease for the week, with a -21.45% drop in the past month and a -16.46% fall in the past quarter. The volatility ratio for the week is 6.16%, and the volatility levels for the past 30 days are at 6.27% for IGC Pharma Inc The simple moving average for the past 20 days is -7.58% for IGC’s stock, with a -15.20% simple moving average for the past 200 days.
IGC Trading at -17.64% from the 50-Day Moving Average
After a stumble in the market that brought IGC to its low price for the period of the last 52 weeks, the company was unable to rebound, for now settling with -63.18% of loss for the given period.
Volatility was left at 6.27%, however, over the last 30 days, the volatility rate increased by 6.16%, as shares sank -14.01% for the moving average over the last 20 days. Over the last 50 days, in opposition, the stock is trading -21.39% lower at present.
During the last 5 trading sessions, IGC fell by -9.53%, which changed the moving average for the period of 200-days by +6.88% in comparison to the 20-day moving average, which settled at $0.3597. In addition, IGC Pharma Inc saw 19.60% in overturn over a single year, with a tendency to cut further gains.
Insider Trading
Reports are indicating that there were more than several insider trading activities at IGC starting from PRINS RICHARD K, who proposed sale 200,000 shares at the price of $0.39 back on Aug 12 ’24. After this action, PRINS RICHARD K now owns shares of IGC Pharma Inc, valued at $78,200 using the latest closing price.
Stock Fundamentals for IGC
Current profitability levels for the company are sitting at:
- -9.47 for the present operating margin
- 0.34 for the gross margin
The net margin for IGC Pharma Inc stands at -12.53. The total capital return value is set at -1.24. Equity return is now at value -126.20, with -101.29 for asset returns.
Based on IGC Pharma Inc (IGC), the company’s capital structure generated 0.03 points at debt to capital in total, while cash flow to debt ratio is standing at -20.16.
Currently, EBITDA for the company is -5.82 million with net debt to EBITDA at 0.17. When we switch over and look at the enterprise to sales, we see a ratio of 22.53. The receivables turnover for the company is 37.93for trailing twelve months and the total asset turnover is 0.1. The liquidity ratio also appears to be rather interesting for investors as it stands at 1.77.
Conclusion
In a nutshell, IGC Pharma Inc (IGC) has experienced a bad performance in recent times. The stock has received mixed “buy” and “hold” ratings from analysts. It’s important to note that the stock is currently trading at a significant distance from its 50-day moving average and its 52-week high.
